Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

331 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Performance of spirometry assessment at TB diagnosis.
Rachow A, Ivanova O, Bakuli A, Khosa C, Nhassengo P, Owolabi O, Jayasooriya S, Ntinginya NE, Sabi I, Rassool M, Bennet J, Niemann S, Mekota AM, Allwood BW, Wallis RS, Charalambous S, Hoelscher M, Churchyard G. Rachow A, et al. Among authors: hoelscher m. Int J Tuberc Lung Dis. 2023 Aug 1;27(11):850-857. doi: 10.5588/ijtld.23.0040. Int J Tuberc Lung Dis. 2023. PMID: 37880896 Free PMC article.
Direct comparison of Xpert MTB/RIF assay with liquid and solid mycobacterial culture for quantification of early bactericidal activity.
Kayigire XA, Friedrich SO, Venter A, Dawson R, Gillespie SH, Boeree MJ, Heinrich N, Hoelscher M, Diacon AH; Pan African Consortium for the Evaluation of Anti-tuberculosis Antibiotics. Kayigire XA, et al. Among authors: hoelscher m. J Clin Microbiol. 2013 Jun;51(6):1894-8. doi: 10.1128/JCM.03290-12. Epub 2013 Apr 17. J Clin Microbiol. 2013. PMID: 23596237 Free PMC article.
A phase IIb, open-label, randomized controlled dose ranging multi-centre trial to evaluate the safety, tolerability, pharmacokinetics and exposure-response relationship of different doses of delpazolid in combination with bedaquiline delamanid moxifloxacin in adult subjects with newly diagnosed, uncomplicated, smear-positive, drug-sensitive pulmonary tuberculosis.
Dierig A, Hoelscher M, Schultz S, Hoffmann L, Jarchow-MacDonald A, Svensson EM, Te Brake L, Aarnoutse R, Boeree M, McHugh TD, Wildner LM, Gong X, Phillips P, Minja LT, Ntinginya N, Mpagama S, Liyoyo A, Wallis RS, Sebe M, Mhimbira FA, Mbeya B, Rassool M, Geiter L, Cho YL, Heinrich N. Dierig A, et al. Among authors: hoelscher m. Trials. 2023 Jun 6;24(1):382. doi: 10.1186/s13063-023-07354-5. Trials. 2023. PMID: 37280643 Free PMC article. Clinical Trial.
Effect of seven anti-tuberculosis treatment regimens on sputum microbiome: a retrospective analysis of the HIGHRIF study 2 and PanACEA MAMS-TB clinical trials.
Musisi E, Wyness A, Eldirdiri S, Dombay E, Mtafya B, Ntinginya NE, Heinrich N, Kibiki GS, Hoelscher M, Boeree M, Aarnoutse R, Gillespie SH, Sabiiti W; PanACEA consortium. Musisi E, et al. Among authors: hoelscher m. Lancet Microbe. 2023 Nov;4(11):e913-e922. doi: 10.1016/S2666-5247(23)00191-X. Epub 2023 Oct 10. Lancet Microbe. 2023. PMID: 37832571 Free article.
Lung outcomes and related risk factors in patients after SARS-CoV-2 infection: a hospitalised single-centre cohort from Johannesburg, South Africa.
Glover NA, Ivanova O, Sathar F, Riess F, Shambhu RR, Mekota AM, Zurba L, Menezes C, Alexandra van Blydenstein S, Kalla I, Hoelscher M, Saathoff E, Charalambous S, Rachow A. Glover NA, et al. Among authors: hoelscher m. EClinicalMedicine. 2024 Apr 11;71:102588. doi: 10.1016/j.eclinm.2024.102588. eCollection 2024 May. EClinicalMedicine. 2024. PMID: 38623400 Free PMC article.
Reflex Xpert MTB/XDR Testing of Residual Rifampicin-Resistant Specimens: A Clinical Laboratory-Based Diagnostic Accuracy and Feasibility Study in South Africa.
Centner CM, Munir R, Tagliani E, Rieß F, Brown P, Hayes C, Dolby T, Zemanay W, Cirillo DM, David A, Schumacher SG, Denkinger CM, Ruhwald M, Leukes VN, Nicol MP, Van der Walt I, Kisten G, Gumede M, Mace A, Brink A, Stevens W, Scott L, Penn-Nicholson A, Cox H; TB-CAPT Consortium. Centner CM, et al. Open Forum Infect Dis. 2024 Jul 31;11(8):ofae437. doi: 10.1093/ofid/ofae437. eCollection 2024 Aug. Open Forum Infect Dis. 2024. PMID: 39165581 Free PMC article.
New admissions and asymptomatic TB cases seem to fuel TB epidemic in prisons, a cross sectional survey in Tanzania.
Mangu CD, Clowes P, van den Hombergh J, Mwakabenga C, Mwanyonga S, Ambindwile J, Kayombo F, Minja M, Kalluvya S, Gerwing-Adima L, Kasang C, Mueller A, Chilolo E, Angolwisye J, Nsajigwa D, Kachima A, Kamala D, Mutayobya B, Ntinginya NE, Hoelscher M, Saathoff E, Rachow A. Mangu CD, et al. Among authors: hoelscher m. PLOS Glob Public Health. 2024 Oct 14;4(10):e0002372. doi: 10.1371/journal.pgph.0002372. eCollection 2024. PLOS Glob Public Health. 2024. PMID: 39401196 Free PMC article.
Impact of drug-resistant tuberculosis on socio-economic status, quality of life and psychological well-being of patients in Bucharest, Romania: a prospective cohort study.
Ramachandran R, Dumitrescu A, Baiceanu D, Popa C, Dragomir A, Mahler B, Hoelscher M, Lange C, Heyckendorf J, Rachow A, Ibraim E, Ivanova O. Ramachandran R, et al. Among authors: hoelscher m. J Health Popul Nutr. 2024 Dec 22;43(1):223. doi: 10.1186/s41043-024-00717-x. J Health Popul Nutr. 2024. PMID: 39710755 Free PMC article.
331 results